# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA653338 | F | Cytotoxicity against CAOV-3 human tumor cell lines | Homo sapiens | 15 | cell-based format | Scientific Literature | ||
2. | ALA653339 | F | In vitro cytotoxicity against CAOV-3 human tumor cell line. | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
3. | ALA653340 | F | Compound was evaluated for in vitro antiproliferative activity against CAOV-3 human ovarian cancer cell line | Homo sapiens | 10 | cell-based format | Scientific Literature | ||
4. | ALA653341 | F | In vitro cytotoxicity against human tumor cell line CAOV-3 | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
5. | ALA657427 | F | Compound was tested for cytotoxicity against CaOv3 human solid tumor cell line | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
6. | ALA657428 | F | Compound was tested for cytotoxicity against CaOv3 human solid tumor cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
7. | ALA657429 | F | Compound was tested for cytotoxicity against CaOv3 human solid tumor cell line; NA=Not active | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
8. | ALA653700 | F | Percent of growth inhibition of Cell line Caov-3(Ovarian) by the compound | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
9. | ALA653701 | F | Percent of growth inhibition of Cell line Caov-3(Ovarian) by the compound | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
10. | ALA653702 | F | Efficacy is growth inhibition activity at 10 uM concentration relative to the maximum activity observed for 4-HPR with Caov-3 cell line | 9 | cell-based format | Scientific Literature | |||
11. | ALA653703 | F | Potency of compound was determined from ability to inhibit the growth of ovarian carcinoma cell line Caov-3 | 9 | cell-based format | Scientific Literature | |||
12. | ALA2363161 | F | SANGER: Inhibition of human Caov-3 cell growth in a cell viability assay. | Homo sapiens | 38 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | ||
13. | ALA4012917 | F | Growth inhibition of human Caov3 cells after 6 days in presence of 1% FBS by Cell-Titer Glo assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
14. | ALA4012944 | F | Growth inhibition of human Caov3 cells at 10 uM after 6 days in presence of 1% FBS by Cell-Titer Glo assay relative to control | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
15. | ALA4012955 | F | Growth inhibition of human Caov3 cells after 6 days in presence of 10% FBS by Cell-Titer Glo assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
16. | ALA4012995 | F | Growth inhibition of human Caov3 cells at 10 uM after 6 days in presence of 10% FBS by Cell-Titer Glo assay relative to control | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
17. | ALA4037479 | F | Antiproliferative activity against human Caov3 cells after 96 hrs | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
18. | ALA4261717 | F | Cytotoxicity against human Caov3 cells assessed as decrease in cell viability after 72 hrs by CCK8 assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
19. | ALA4275267 | F | Antiproliferative activity against human Caov3 cells measured after 96 hrs | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
20. | ALA4343280 | F | Antiproliferative activity against human Caov3 cells by SRB assay | Homo sapiens | 1 | cell-based format | Scientific Literature |